This inventor holds 1 USPTO granted patent. Top assignee: The South China University of Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Youyong Yuan: Innovator in Protein-Type Nanoparticles
Introduction
Youyong Yuan is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of protein-type nanoparticles. His innovative work focuses on enhancing the delivery of multi-specific antibodies, which has important implications for therapeutic applications.
Latest Patents
Youyong Yuan holds a patent for "Protein-type nanoparticles, preparation methods, and application thereof." This patent describes a protein-type nanoparticle designed for multi-specific antibody delivery. The nanoparticle comprises a polyester and a protein with a hydrophobic domain, which is bound to the polyester through hydrophobic interactions. The proteins involved include albumin, globulin, and cell wall protein. The nanoparticle exhibits excellent stability and biocompatibility, making it suitable for preparing a multi-specific antibody delivery platform (αFc-NP). This platform can effectively bind to multiple specific antibodies, enhancing their therapeutic effects through antigen-antibody interactions.
Career Highlights
Youyong Yuan is affiliated with the South China University of Technology, where he continues to advance his research in nanotechnology and biotechnology. His work has garnered attention for its potential to improve medical treatments and drug delivery systems.
Collaborations
Youyong Yuan collaborates with notable colleagues, including Jun Wang and Zhiting Cao. Their combined expertise contributes to the innovative research and development of new technologies in their field.
Conclusion
Youyong Yuan's contributions to the field of protein-type nanoparticles represent a significant advancement in biotechnology. His patented innovations have the potential to enhance therapeutic applications and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile